Ventricular Arrythmia clinical trials

Explore recruiting ventricular arrythmia clinical trials.

Recruiting ventricular arrythmia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Ventricular Arrythmia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A PHASE 2A, INVESTIGATOR AND SUBJECT BLINDED, SPONSOR UNBLINDED, PLACEBO-CONTROLLED, CLINICAL STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF CRD-4730 IN PARTICIPANTS WITH CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA

France, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2a Trial to Investigate Safety, Tolerability and Exploratory Clinical Efficacy of AGP100 in Patients with Catecholaminergic Polymorphic Ventricular Tachycardia

Norway

Therapeutic exploratory (Phase II) EU CTIS Study details

A PHASE 2, DOUBLE-BLIND, REPEAT-DOSE, PLACEBO-CONTROLLED CROSSOVER STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF CRD-4730 IN PARTICIPANTS WITH CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA

Netherlands, Spain, France, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Danish trial of beta blocker treatment after myocardial infarction without reduced ejection fraction (DANBLOCK)

Denmark

Therapeutic confirmatory (Phase III) EU CTIS Study details

Ventricular Arrythmia trials by city

Ventricular Arrythmia in Toronto Ventricular Arrythmia in Vancouver Ventricular Arrythmia in Montreal Ventricular Arrythmia in Calgary Ventricular Arrythmia in Edmonton Ventricular Arrythmia in Ottawa Ventricular Arrythmia in Winnipeg Ventricular Arrythmia in Quebec City Ventricular Arrythmia in Hamilton Ventricular Arrythmia in Kitchener Ventricular Arrythmia in London Ventricular Arrythmia in Halifax Ventricular Arrythmia in New York Ventricular Arrythmia in Los Angeles Ventricular Arrythmia in Chicago Ventricular Arrythmia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease